Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer - Quiz - MDSpire

Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer

A new study from Dana-Farber Cancer Institute finds that patients with NUT carcinoma (NC), an aggressive squamous cell lung or head and neck cancer, often face delays in diagnosis—delays that can prevent them from receiving the right treatment or joining clinical trials.

  • By

  • December 8, 2025

  • 3 min

Share

Original Source(s)

Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer

  • by

  • December 8, 2025

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma